Phenotypic Features of 26 Patients With Large-Cell Transformation
| Patient No. . | Age-150 . | Interval From Dx of MF/SS to Transformation (mo) . | Stage at Diagnosis . | Stage at Transformation . | Site of Transformation . |
|---|---|---|---|---|---|
| 1 | 56 | 1 | IB (T2N0M0) | IB (T2N0M0) | Skin |
| 2 | 66 | 1 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 3 | 65 | 87 | IIIA (T4N0M0) | IIIA (T4N0M0) | Skin |
| 4 | 71 | 0 | IIA (T2N1M0) | IIA (T2N1M0) | Skin |
| 5 | 69 | 75 | IB (T2N0M0) | IB (T2N0M0) | Skin |
| 6 | 51 | 75 | IB (T2N0M0) | IB (T2N0M0) | Skin |
| 7 | 33 | 5 | IIA (T2N1M0) | IIA (T2N1M0) | Skin |
| 8 | 72 | 128 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 9 | 50 | 29 | IIB (T3N1M0) | IIB (T3N1M0) | Skin |
| 10 | 65 | 17 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 11 | 29 | 5 | IIB (T3N1M0) | IIB (T3N1M0) | Skin |
| 12 | 72 | 0 | IVA (T4N3M0) | IVA (T4N3M0) | Skin, lymph node |
| 13 | 64 | 0 | IVA (T3N3M0) | IVA (T3N3M0) | Skin, lymph node |
| 14 | 65 | 12 | IVA (T3N3M0) | IVA (T3N3M0) | Skin |
| 15 | 65 | 0 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 16 | 59 | 12 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 17 | 62 | 21 | IIIA (T4N0M0) | IIIA (T4N0M0) | Skin |
| 18 | 69 | 22 | IVA (T3N3M0) | IVA (T3N3M0) | Skin |
| 19 | 75 | 0 | IVB (T4N1M1) | IVB (T4N1M1) | Skin |
| 20 | 68 | 1 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 21 | 80 | 78 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 22 | 53 | 26 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 23 | 78 | 0 | IB (T2N0M0) | IB (T2N0M0) | Skin |
| 24 | 60 | 7 | IIA (T2N1M0) | IIA (T2N1M0) | Skin |
| 25 | 62 | 26 | IB (T2N0M0) | IVB (T2N1M1) | Liver |
| 26 | 40 | 22 | IIIA (T4N0M0) | IVA (T4N1M0) | Lymph node |
| Patient No. . | Age-150 . | Interval From Dx of MF/SS to Transformation (mo) . | Stage at Diagnosis . | Stage at Transformation . | Site of Transformation . |
|---|---|---|---|---|---|
| 1 | 56 | 1 | IB (T2N0M0) | IB (T2N0M0) | Skin |
| 2 | 66 | 1 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 3 | 65 | 87 | IIIA (T4N0M0) | IIIA (T4N0M0) | Skin |
| 4 | 71 | 0 | IIA (T2N1M0) | IIA (T2N1M0) | Skin |
| 5 | 69 | 75 | IB (T2N0M0) | IB (T2N0M0) | Skin |
| 6 | 51 | 75 | IB (T2N0M0) | IB (T2N0M0) | Skin |
| 7 | 33 | 5 | IIA (T2N1M0) | IIA (T2N1M0) | Skin |
| 8 | 72 | 128 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 9 | 50 | 29 | IIB (T3N1M0) | IIB (T3N1M0) | Skin |
| 10 | 65 | 17 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 11 | 29 | 5 | IIB (T3N1M0) | IIB (T3N1M0) | Skin |
| 12 | 72 | 0 | IVA (T4N3M0) | IVA (T4N3M0) | Skin, lymph node |
| 13 | 64 | 0 | IVA (T3N3M0) | IVA (T3N3M0) | Skin, lymph node |
| 14 | 65 | 12 | IVA (T3N3M0) | IVA (T3N3M0) | Skin |
| 15 | 65 | 0 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 16 | 59 | 12 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 17 | 62 | 21 | IIIA (T4N0M0) | IIIA (T4N0M0) | Skin |
| 18 | 69 | 22 | IVA (T3N3M0) | IVA (T3N3M0) | Skin |
| 19 | 75 | 0 | IVB (T4N1M1) | IVB (T4N1M1) | Skin |
| 20 | 68 | 1 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 21 | 80 | 78 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 22 | 53 | 26 | IIB (T3N0M0) | IIB (T3N0M0) | Skin |
| 23 | 78 | 0 | IB (T2N0M0) | IB (T2N0M0) | Skin |
| 24 | 60 | 7 | IIA (T2N1M0) | IIA (T2N1M0) | Skin |
| 25 | 62 | 26 | IB (T2N0M0) | IVB (T2N1M1) | Liver |
| 26 | 40 | 22 | IIIA (T4N0M0) | IVA (T4N1M0) | Lymph node |
Abbreviation: Dx, diagnosis.
Age of the patients at transformation.